2022. In-Depth In Silico Investigation Of Gitalin And Glaziovine As Possible VEGFR-2 Kinase Inhibitors For The Treatment Of Cancer. Journal of Pharmaceutical Negative Results. (Dec. 2022), 6523–6531. DOI:https://doi.org/10.47750/.